Tilray Brands announced the launch of PORTAL™, a new high‑intensity cannabis brand, on April 08 2026. The brand is designed for seasoned, high‑tolerance consumers and features liquid diamonds—Canada’s highest‑potency THC‑dominant concentrate—as well as diamond‑coated flower. The products include infused pre‑rolls with THC levels exceeding 40 % and liquid‑diamond vape cartridges that contain 95‑99 % THC.
PORTAL™ will be sold in select Canadian retailers, with availability varying by province. The launch is positioned as a ritual‑focused, sci‑fi‑inspired line that promises uncompromising performance and consistency for experienced users. By adding a premium, high‑potency option, Tilray aims to capture a niche segment that seeks intensity and reliability, potentially boosting sales in the growing high‑potency cannabis market.
Management said, "As the infused category matures, a clear gap has emerged between consumer expectations and product performance. PORTAL is purpose‑built for experienced consumers with high tolerance and uncompromising expectations—delivering precision, consistency, and elevated performance. This launch underscores Tilray’s ability to identify gaps in the market and lead with differentiated brands that set a new standard for the category." The statement highlights Tilray’s focus on product differentiation and its strategy to address unmet demand in the infused and vape segments.
Tilray’s broader portfolio includes cannabis, beverages, and wellness products, and the company has reported record annual revenue of $821 million in fiscal year 2025. While the PORTAL™ launch is a new product line, it aligns with Tilray’s ongoing effort to diversify revenue streams and strengthen its position in Canada’s competitive cannabis market.
The introduction of PORTAL™ expands Tilray’s infused and vape categories, addressing a market gap identified by the company’s leadership. By offering a premium, high‑potency option, Tilray seeks to capture a niche segment that values intensity and reliability, potentially boosting sales in the high‑potency cannabis segment.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.